Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis

被引:70
作者
Bauer, Marlijn P.
Hensgens, Marjolein P. M.
Miller, Mark A. [2 ]
Gerding, Dale N. [3 ,4 ]
Wilcox, Mark H. [5 ,6 ]
Dale, Adam P. [5 ]
Fawley, Warren N. [5 ]
Kuijper, Ed J. [1 ]
Gorbach, Sherwood L. [7 ,8 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands
[2] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada
[3] Vet Affairs Edward Hines Jr Hosp, Maywood, IL USA
[4] Loyola Univ, Chicago Sch Med, Maywood, IL 60153 USA
[5] Univ Leeds, Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS2 9JT, W Yorkshire, England
[6] Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England
[7] Tufts Univ, Sch Med, Boston, MA 02111 USA
[8] Optimer Pharmaceut Inc, San Diego, CA USA
关键词
RISK-FACTORS; COLITIS; EPIDEMIOLOGY; SEVERITY; RELAPSE; SOCIETY; DISEASE;
D O I
10.1093/cid/cis340
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nonsevere Clostridium difficile infection (CDI) and severe CDI, which carries a higher risk than nonsevere CDI for treatment failure and CDI recurrence, are difficult to distinguish at the time of diagnosis. To investigate the prognostic value of 3 markers of severe CDI suggested by recent guidelines (fever, leukocytosis, and renal failure), we used the database of 2 randomized controlled trials, which contained information for 1105 patients with CDI. Leukocytosis (risk ratio [RR], 2.29; 95% confidence interval [CI], 1.63-3.21) and renal failure (RR, 2.52; 95% CI, 1.82-3.50) were associated with treatment failure. Fever, although associated with treatment failure (RR, 2.45; 95% CI, 1.07-5.61), was rare. Renal failure was the only significant predictor of recurrence (RR, 1.45; 95% CI, 1.05-2.02). Different timing of measurements of leukocyte count and serum creatinine level around the CDI diagnosis led to a different severity classification in many cases. In conclusion, both leukocytosis and renal failure are useful predictors, although timing of measurement is important.
引用
收藏
页码:S149 / S153
页数:5
相关论文
共 14 条
[1]   European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI) [J].
Bauer, M. P. ;
Kuijper, E. J. ;
van Dissel, J. T. .
CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) :1067-1079
[2]   Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system [J].
Belmares, Jaime ;
Gerding, Dale N. ;
Parada, Jorge P. ;
Miskevics, Scott ;
Weaver, Frances ;
Johnson, Stuart .
JOURNAL OF INFECTION, 2007, 55 (06) :495-501
[3]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[4]  
Crook D, 2010, INF DIS SOC AM 48 AN
[5]   Comparison of Clinical Severity Score Indices for Clostridium difficile Infection [J].
Fujitani, Shigeki ;
George, W. Lance ;
Murthy, A. Rekha .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (03) :220-228
[6]   Clinical Risk Factors for Severe Clostridium difficile-associated Disease [J].
Henrich, Timothy J. ;
Krakower, Douglas ;
Bitton, Asaf ;
Yokoe, Deborah S. .
EMERGING INFECTIOUS DISEASES, 2009, 15 (03) :415-422
[7]   Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection [J].
Hu, Mary Y. ;
Katchar, Kianoosh ;
Kyne, Lorraine ;
Maroo, Seema ;
Tummala, Sanjeev ;
Dreisbach, Valley ;
Xu, Hua ;
Leffler, Daniel A. ;
Kelly, Ciaran P. .
GASTROENTEROLOGY, 2009, 136 (04) :1206-1214
[8]   A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C-difficile-associated disease in Quebec [J].
Hubert, Bruno ;
Loo, Vivian G. ;
Bourgault, Anne-Marie ;
Poirier, Louise ;
Dascal, Andre ;
Fortin, Elise ;
Dionne, Marc ;
Lorange, Manon .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :238-244
[9]   Fidaxomicin versus Vancomycin for Clostridium difficile Infection [J].
Louie, Thomas J. ;
Miller, Mark A. ;
Mullane, Kathleen M. ;
Weiss, Karl ;
Lentnek, Arnold ;
Golan, Yoav ;
Gorbach, Sherwood ;
Sears, Pamela ;
Shue, Youe-Kong .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05) :422-431
[10]   Health Care-Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality [J].
Miller, Mark ;
Gravel, Denise ;
Mulvey, Michael ;
Taylor, Geoffrey ;
Boyd, David ;
Simor, Andrew ;
Gardam, Michael ;
McGeer, Allison ;
Hutchinson, James ;
Moore, Dorothy ;
Kelly, Sharon .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) :194-201